Clinical Updates
Drug approvals, guideline changes, and treatment advances
Digital Therapy Platform Cuts Depression and Anxiety in Dementia Caregivers by Six Months
Researchers at the University of East Anglia have shown that a mobile-delivered digital therapy platform significantly reduces depression and anxiety…
Editor's Top Picks
Serotonin and Heart Valve Disease: Columbia Study Links SSRIs to Accelerated Mitral Regurgitation
Columbia University researchers have identified a potentially significant interaction between selective serotonin reuptake inhibitors (SSRIs) and degenerative mitral regurgitation, suggesting…
Submit Your Paper →
More form Clinical Updates
Survodutide Weekly Injection Shows 17.5% Weight Loss in Phase 3 Obesity Trial
Phase 3 trial shows survodutide weekly injection achieved 17.5% weight loss versus 1.2% placebo in…
Flavanol-Rich Fruits Could Cut Heart Disease Risk, New Multi-Institutional Study Shows
New research from University of Reading, Harvard Medical School, and UC Davis shows that flavanol-rich…
Diabetes Drug Dapagliflozin Cuts Heart Failure Risk by 32% in Genetically Vulnerable Patients
New research shows dapagliflozin reduces heart failure risk by 32% in patients with cardiomyopathy-associated genetic…
NHS Approves First New Ovarian Cancer Drug in 20 Years for Resistant Disease
NHS approves mirvetuximab soravtansine, the first new ovarian cancer treatment in over 20 years for…
New NEJM Trial Shows Romiplostim Reduces Chemotherapy-Induced Thrombocytopenia Risk
A randomized controlled trial in NEJM shows romiplostim significantly reduces chemotherapy-induced thrombocytopenia compared to placebo.…